Sanofi (LON: 0A2V)

Market Cap	94.81B
Revenue (ttm)	40.31B
Net Income (ttm)	3.75B
Shares Out	n/a
EPS (ttm)	2.99
PE Ratio	25.28
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	341
Open	46.93
Previous Close	47.54
Day's Range	46.90 - 47.84
52-Week Range	35.79 - 46.86
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 30, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric ...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 86,088
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A2V

Financial Performance

In 2023, Sanofi's revenue was 46.03 billion, an increase of 1.42% compared to the previous year's 45.39 billion. Earnings were 5.40 billion, a decrease of -35.49%.

Financial numbers in EUR